Oyster Point Pharma Inc. (OYST)
NASDAQ: OYST
· Real-Time Price · USD
11.17
0.00 (0.00%)
At close: Dec 30, 2022, 9:00 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 19.58M |
| Net Income (ttm) | -188.97M |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 2,088,283 |
| Avg. Volume (20D) | 417,562 |
| Open | 11.16 |
| Previous Close | 11.17 |
| Day's Range | 11.12 - 11.20 |
| 52-Week Range | 3.46 - 13.45 |
| Beta | 0.00 |
About OYST
As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also d...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 31, 2019
Employees 303
Stock Exchange NASDAQ
Ticker Symbol OYST
Website https://www.oysterpointrx.com